EP2152917
GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.5.2008EP published:
23.3.2016EP application number:
08755809.4
EPO information:
European Patent Register
Max expiry date:
16.5.2028
Title:
GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS
Timeline
Today
17.5.2008EP application
23.3.2016EP Publication
Owner
Name:
Vanda Pharmaceuticals Inc.Address:
9605 Medical Center Drive, Suite 300, 20850, Rockville NY, US
Inventor
Name:
LAVEDAN, ChristianAddress:
Potomac, MD, US
Name:
VOLPI, SimonaAddress:
Derwood, MD, US
Name:
LICAMELE, LouisAddress:
Gaithersburg, MD, US
Name:
POLYMEROPOULOS, Mihael, H.Address:
Potomac, MD, US
Priority
Number:
939033 PDate:
18.5.2007Country:
US
Classification
Categories:
C12Q 1/68